Tid Tittel Kategori Vedlegg
20.04.2026
16:31
Photocure ASA: Update on milestone payments from Asieris Pharmaceuticals INFORMASJON INF -
13.04.2026
08:30
Photocure ASA: Update on Regulatory Classification for OAY Equipment -
1
16.03.2026
17:00
Photocure: Trials in Progress presented at the European Association of Urology (EAU) 2026 congress aim to enable a more personalized bladder cancer care pathway -
1
03.03.2026
10:35
Asieris: CEVIRA Approved in China as First-in-Class Non-Invasive Therapy for Cervical Precancerous Lesions -
1
18.02.2026
07:00
Photocure ASA: Results for the fourth quarter of 2025 RAPPORT RAP
3
11.02.2026
17:06
Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2025 financial results - -
12.01.2026
17:42
New publication of Hexvix trial data from China: blue light cystoscopy with Hexvix significantly improves the detection of bladder cancer using modern HD equipment -
1
08.12.2025
08:00
The impact of avoiding recurrence: New BRAVO Study abstract at SUO 2025 demonstrates Cost Neutrality in Blue Light versus White Light Cystoscopy comparison -
1
19.11.2025
08:00
New budget impact model study in 4 European countries concludes that BLC use offers a clinically meaningful and economically rational approach to NMIBC management -
1
31.10.2025
08:24
Photocure ASA: Notification of primary insider transaction INSIDEHANDEL INS
2
29.10.2025
07:00
Photocure ASA: Results for the third quarter of 2025 RAPPORT RAP
3
24.10.2025
08:20
Photocure ASA: Invitation to presentation of third quarter 2025 financial results - -
15.10.2025
17:08
Photocure and Intelligent Scopes Corporation partner on development of AI for blue light cystoscopy -
1